![Impact of patient characteristics on the clinical efficacy of mongersen (GED-0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease]()
Impact of patient characteristics on the clinical efficacy of mongersen (GED-0301), an oral Smad7 antisense oligonucleotide, in active Crohn's diseaseMonteleone, G.; Di Sabatino, A.; Ardizzone, S.; Pallone, F.; Usiskin, K.; Zhan, X.; Rossiter, G.; Neurath, M. F. · Alimentary Pharmacology & Therapeutics · 2016